MD Mednax Earnings and EPS analysis

EPS in 2026 (TTM): $2.09

Last Report Period Date: Mar 31, 2026

As of June 2026, MD's trailing twelve months (TTM) EPS stands at $2.09, according to the latest financial reports. In 2025, the company recorded an earnings per share (EPS) of $1.97, which represents an increase compared to its EPS of -$1.19 in 2024. MD reported an EPS of $0.37 for the quarterly report ending on Mar 31, 2026.

For 2025, Mednax's EPS was $1.97, an increase of 265.5% from -$1.19 in 2024. For the quarter ending Mar 31, 2026, the EPS was $0.37, showing a 48% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2026 is $2.09. In 2024, the annual EPS was -$1.19, showing a decrease of 63% from 2023.

Mednax has recorded an increase in EPS of 48% over the last 12 months (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of 35.6% per year over the past 3 years. A 10-year view shows that MD has seen an average EPS growth of -5.9% per year.